Is Lakefront Biotherapeutics Nv Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: LKFT) stock is to Hold LKFT stock.
Out of 1 analyst, 0 (0%) are recommending LKFT as a Strong Buy, 0 (0%) are recommending LKFT as a Buy, 1 (100%) are recommending LKFT as a Hold, 0 (0%) are recommending LKFT as a Sell, and 0 (0%) are recommending LKFT as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year LKFT price target, the average LKFT price target is $33.00, with the highest LKFT stock price forecast at $33.00 and the lowest LKFT stock price forecast at $33.00.
The Wall Street analyst predicted that Lakefront Biotherapeutics Nv's share price could reach $33.00 by Feb 25, 2027. The average Lakefront Biotherapeutics Nv stock price prediction forecasts a potential upside of 20.22% from the current LKFT share price of $27.45.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.